Peninsula Pharmaceuticals
Peninsula Pharmaceuticals
Focused on development and commercialization of antibiotics
Human health & social work | Northern America | Health Improvement |
Overview
Peninsula was acquired by Johnson & Johnson on June 30th 2005. Peninsula is a biopharmaceutical company focused on the development and commercialization of antibiotics to treat life threatening infections. The Company s mission is to develop optimal anti infective therapies that offer improved efficacy dosing and safety characteristics over existing therapies. In addition to DBL Investors investors include Canaan Partners and Domain Associates.
Industry |
Legal Structure |
Operating Status |
Employees |
Human health & social work | Out of Business |
Funding and Financing Rounds
Undisclosed
Team
Impact
Geographies:
Social Objectives:
Environmental Objectives:
Operational Impact:
Impact Reports & Metrics
Offices
Peninsula Pharmaceuticals
1751 Harbor Bay Parkway
Alameda, California 94502
United States of America